| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ca-activated Cl currents (ICl(Ca)) are used frequently as reporters in functional studies of anesthetic effects on G protein-coupled receptors using Xenopus laevis oocytes. However, because anesthetics affect protein kinase C (PKC), they could indirectly affect ICl(Ca) if this current is regulated by phosphorylation. We therefore studied the effect of modulation of either PKC or protein phosphatases PP1 and PP2A on ICl(Ca) stimulated either by lysophosphatidate (LPA) signaling or by microinjection of Ca. X. laevis oocytes were studied under voltage clamp. Rat PP1 and PP2A were overexpressed in oocytes. PP, inositoltrisphosphate (IP3), the PP inhibitor okadaic acid (OA), the PKC inhibitor chelerythrine, or CaCl2 were directly injected into the oocyte. Responses to agonists (LPA 106 M, IP3 104 M, CaCl2 0.5 M) were measured at a holding potential of 70 mV in the presence or absence of the PP inhibitors cantharidin or OA. PP1 and PP2A inhibited ICl(Ca) from 7.6 ± 0.9 µC to 2.5 ± 0.9 µC and 3.2 ± 1.4 µC, respectively. PP inhibition enhanced ICl(Ca) in control oocytes and reversed the inhibitory effect in oocytes expressing PP1 or PP2A. PKC inhibition by chelerythrine enhanced both LPA- and CaCl2-induced ICl(Ca). Our data indicate that the Xenopus ICl(Ca) is modulated by phosphorylation. This may complicate design and interpretation of studies of G protein-coupled receptors using this model. IMPLICATIONS: The Xenopus ICl(Ca), commonly used as a reporter current in studies of anesthetic effects on G protein-coupled signaling, is modulated by phosphorylation. Anesthetic effects on channel phosphorylation state can therefore be misinterpreted as effects on receptor signaling.
Oocytes of the frog Xenopus laevis have become a commonly used model for the study of anesthetic effects on G protein-coupled receptors (GPCR). Particularly receptors that couple to Gq/11/14 proteins, which induce intracellular Ca release, are easily investigated in this model (1,2), as an endogenous Ca-activated Cl current (ICl(Ca)) provides a convenient end-point assay of changes in intracellular Ca concentration. Anesthetics could potentially affect ICl(Ca) directly, and such interactions of the anesthetic with the reporter channel could be misinterpreted as interactions with the receptor signaling pathway. To exclude such an action, it has generally been considered sufficient to demonstrate that anesthetics do not affect ICl(Ca) induced by a receptor-independent increase in intracellular Ca concentrations (e.g., by microinjection of CaCl2). For many anesthetics (general as well as local) a lack of effect on receptor-independent ICl(Ca) has been demonstrated. However, we suggest that this may not be sufficient evidence to exclude anesthetic modulation of ICl(Ca). Activation of Gq/11/14-coupled receptors will, in addition to increasing intracellular Ca levels, result in generation of diacylglycerol (DAG), which will activate protein kinase C (PKC). If PKC were to regulate ICl(Ca) by channel phosphorylation, an effect of anesthetics on PKC activity could be misinterpreted as an effect on receptor signaling. Importantly, receptor-independent ICl(Ca) would not be affected by anesthetic in this scenario. In addition to affecting PKC, anesthetics might interact with protein phosphatases (PP), which dephosphorylate targets of PKC. This might also result in effects on ICl(Ca) that could be misinterpreted as actions on receptor signaling. We hypothesized that the X. laevis ICl(Ca) is modulated by PKC and/or PP. To test this hypothesis, we investigated the effects of activation and inhibition of PKC, as well as overexpression and inhibition of PP, on receptor-, inositoltrisphosphate (IP3)-, or Ca-induced ICl(Ca) in Xenopus oocytes.
Isolation of X. laevis Oocytes The study protocol was approved by the local Animal Care and Use Committee. Xenopus oocytes were removed as described previously (3). In brief, frogs were anesthetized by immersion in cold 0.2% 3-amino-benzoic-methyl-ester until fully immobile. After abdominal incision an ovarian lobule, containing approximately 200 cells, was removed under sterile conditions. The frogs were allowed to recover from anesthesia and operation in a separate tank. Oocytes were maintained at 20°C in modified Barths solution (containing 88 mM NaCl, 2.4 mM NaHCO3, 0.41 mM CaCl2, 0.82 mM MgSO4, 0.3 mM Ca2NO3, 0.1 mM gentamycin, and 15 mM HEPES, pH adjusted to 7.4). Oocytes were defolliculated by gentle shaking in 1 mg/mL solution of collagenase type A in calcium-free OR2 solution (containing 82.5 mM NaCl, 2 mM KCl, 1 mM MgCl2, and 5 mM HEPES, pH adjusted to 7.4). After 2 h the cells were returned to modified Barths solution. Microscopic observation confirmed that the follicle cells had been removed.
PP Overexpression
Electrophysiology Receptor agonist (lysophosphatidate, LPA) was delivered as a 30 µL aliquot (Tyrodes solution containing 0.1% fatty acid free bovine serum albumin [BSA]) over a period of 2 s using a hand-held micropipette positioned approximately 2 mm in front of the oocyte.
Intracellular Microinjection
PP Assay
Data Analysis
Materials
PKC Modulates ICl(Ca) The phospholipid LPA induces ICl(Ca) by activating an endogenous receptor in the oocyte and was used in this investigation as a method for inducing receptor-mediated ICl(Ca). We demonstrated previously that LPA signaling in oocytes is modulated by PKC (2). We now compared the effect of altering PKC activity on LPA-induced ICl(Ca) with its effect on receptor-independent activation of ICl(Ca) by intracellular injection of CA. LPA induced transient ICl(Ca), as described previously. EC50 was calculated from the concentration-response relationship and was 5.4 ± 0.2 x 107 M (Fig. 1A). A concentration of 106 M was used for all subsequent experiments.
Inhibition of PKC with the antagonist chelerythrine enhanced LPA responses by 65% (Fig. 1B). These findings are comparable with those reported previously (2). Receptor-independent ICl(Ca), induced by intracellular injection of Ca, was enhanced in the presence of chelerythrine (91%, Fig. 1B). This finding indicates that ICl(Ca) is modulated by PKC activity.
PP Overexpression Modulates LPA-Induced ICl(Ca)
Endogenous PP Modulate LPA-Induced ICl(Ca) As overexpression of PP inhibits LPA-induced ICl(Ca), it appears conceivable that endogenous oocyte PP might similarly affect this pathway. To test this hypothesis and to exclude potential artifactual effects resulting from overexpression of PP, we determined the effect of PP inhibitors on LPA-induced ICl(Ca). Cantharidin (105 M) increased LPA-induced ICl(Ca) in KCl-injected oocytes (Fig. 3C), suggesting the presence of endogenous PP in X. laevis oocytes and that LPA signaling is regulated by activity of these PP. OA (105 M) similarly increased LPA-induced ICl(Ca) in control oocytes (Fig. 3C)
Endogenous PP Modulate IP3- or Ca-Induced ICl(Ca)
The main findings of the present study are that receptor-independent ICl(Ca) is modulated by both PKC and PP and that, interestingly, the targets of PP and PKC appear to be different. Whereas a decrease in phosphorylation state induced by inhibition of PKC enhances ICl(Ca), decreasing phosphorylation by overexpression of PP inhibits responses. This could imply that PKC phosphorylates different sites on the Cl channel than are dephosphorylated by PP and that these various sites have different functions. Alternatively, one (or both) of the enzymes could act indirectly, i.e., PKC could phosphorylate a protein that in turn modulates the Cl channel. Our data do not allow us to differentiate between these options but do indicate that the oocyte ICl(Ca) is a current heavily regulated by phosphorylation and dephosphorylation. These findings are of relevance for studies of anesthetics on signaling systems using the Xenopus oocyte ICl(Ca) as reporter. In such studies, the target of interest is usually a G protein-coupled receptor expressed in oocytes by injection of complementary RNA or DNA. Such receptors couple effectively to endogenous Xenopus G proteins, and those receptors that activate Gq, G11 and/or G14 proteins will induce an IP3-mediated increase in intracellular Ca levels. This, in turn, will activate ICl(Ca). Whereas the expressed receptor is often of mammalian origin, and the G proteinphospholipase CIP3 receptor pathway in oocytes has been shown to be functionally similar to its mammalian counterpart, the frog Ca-activated Cl channel is not a part of this signaling system in mammals. Thus, an anesthetic effect on ICl(Ca) would be of limited relevance, and it is therefore appropriate to assure that any anesthetic effects observed take place upstream of the Cl channel. To determine the anesthetic site of action, control experiments are often performed in which ICl(Ca) is activated by direct injection into the oocyte of either IP3 or Ca. If ICl(Ca) induced by this means is not affected by the anesthetic, this is taken to imply that the anesthetic is not affecting the Ca-activating Cl channel. Our data suggest that this control experiment may not be sufficient. Activation of Ca-signaling G proteins also induces the release of DAG, which in turn will activate PKC. Our findings indicate that PKC activation by this means is likely to increase phosphorylation of the Cl channel, resulting in decreased currents. Many anesthetics, volatile as well as local, affect PKC (5,6). Interactions are complex and depend both on the specific anesthetic studied and the PKC subtypes present in the model under study. In Xenopus oocytes, it appears that at least some volatile anesthetics increase PKC activity. For example, halothane inhibits muscarinic signaling in this model (7), but this effect is abolished completely by pretreatment of the cells with PKC antagonists (8). In contrast, local anesthetics appear to inhibit PKC (9). If receptors are activated in the presence of anesthetic, PKC activity induced by receptor signaling will be modulated by the anesthetic, and ICl(Ca) will be altered. If, however, the channel is activated directly by injection of Ca, no PKC activation will occur, and ICl(Ca) will therefore not be modulated by the presence of anesthetics. Therefore, differences in ICl(Ca) measured in the presence and absence of anesthetic could be misinterpreted as an anesthetic effect on the proximal receptor signaling pathway. A similar argument could be made for the role of PP. However, essentially nothing is known of the interactions between anesthetics and PP. We suggest that the appropriate control experiments would be to determine the effect of anesthetics on ICl(Ca) induced by receptor signaling or by Ca injection in the presence of PKC and PP inhibitors. Alternatively, a more proximal (and admittedly less convenient) end-point (e.g., IP3 production) could be used. Our findings also have some implications for studies of receptor physiology in oocytes, as it is possible to misconstrue an effect of PKC on ICl(Ca) as an effect on the receptor. For example, we have shown previously that LPA signaling in oocytes is regulated by PKC: LPA signaling was affected by either PKC inhibition or activation (2). In view of the current findings, it can not be excluded that such effects on signaling are an action on the Cl channel, rather than on the LPA receptor. In this particular instance, however, this seems not to be the case. Kim et al. (1) also investigated PKC regulation of LPA signaling and observed that PKC activation not only abolished LPA-induced ICl(Ca) but also the increase in IP3 levels induced by LPA signaling. Conversely, inhibiting PKC enhanced IP3 production. This indicates that the role of PKC is indeed proximal in the signaling pathway. The modulation of the Xenopus ICl(Ca) by channel phosphorylation has not been studied in detail. The effect appears to be somewhat specific to PKC, as Chen et al. (10) reported that protein kinase A is without effect on the Ca-activated Cl channel. They did observe an effect of increased cyclic adenosine monophosphate (cAMP) concentrations on ICl(Ca) but demonstrated that this action was indirect and occurred by enhancement of endogenous Ca currents. Of regulation by PP virtually nothing is known. Chen et al. (10) demonstrated previously that injection of PP 1 and 2A attenuated a cAMP-induced increase of ICl(Ca) (10), and our observations that inhibition of PP increases ICl(Ca) above baseline indicates that regulation of channel activity by PP occurs under basal conditions. However, we have not conclusively shown that it is the channel itself that is being directly phosphorylated and dephosphorylated. It is conceivable that the activity of another regulatory molecule would be modulated by phosphorylation, and in turn would regulate the channel. In summary, we have demonstrated that the X. laevis oocyte ICl(Ca) is modulated by both PKC and PP. These findings should be taken into account in the interpretation of studies using ICl(Ca) as a reporter for determining effects of anesthetics on GPCR, as well as in the design of such studies.
Supported, in part, by the Department of Anesthesiology and Critical Care, University Hospital, Muenster, Germany.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|